Aetos Technologies is a technology development company founded to bridge the gap between university-based research and the commercial market. Aetos provides an innovative approach to the technology development process including evaluation, product/process development, business management and financing. Aetos, an equity partner with Auburn University, will also participate in co-development projects with other private companies, research institutions and universities to commercialize additional technologies. More Information Aetos Website

Using novel clustering software, Applications Quest seeks to help institutions of higher education realize their diversity objectives in a manner that is effective, measurable, reproducible, and in conformity with the law. Applications Quest Website

Aunigma is launching next generation network security integrated into high performance protocols to address new and expanding communication platforms and related internet security threats.

FoodSource Lures are the world's only molded fishing lures made entirely of edible ingredients, and are the only manufactured lures to be designated as "natural bait" by fish and wildlife agencies. Ingredients are from renewable resources. FoodSource Lures are available at many fine retailers of fishing items. The Company also is expanding into other product lines with its patented animal food technology. More Information FoodSource Lures Website

HaloSource is a health sciences company that manufactures products and ingredients to serve the water treatment, biomedical, industrial and home markets. It leverages cutting-edge processes to refine chitin and chitosan for water-clarification and various biomedical products. With N-halamine technology, the company is developing antimicrobial and antiviral filters, coatings and textiles to purify water and improve sanitation in homes, healthcare settings and a multitude of environments. More Information HaloSource Website

This newly formed company will develop and commercialize Auburn's reversible heparin/protamine sensor device. More Information

Immtech is a pharmaceutical company developing and commercializing drugs to treat infectious diseases, and the Company is expanding targeted markets by applying its proprietary pharmaceutical platform to treat many other disorders. The Company has advanced clinical programs that include new treatments for malaria, Pneumocystis pneumonia and African sleeping sickness (Trypanosomiasis) and drug development programs for tuberculosis and fungal infections. Immtech has worldwide licensing and exclusive commercialization rights to a large library of well-defined compounds from which a pipeline of therapeutic products could be developed. Immtech works closely with a large scientific consortium of which Auburn is a member. More Information Immtech Pharmaceuticals Website

Microfibrous materials are an enabling technology that allows chemical reactions and processes to occur far more efficiently than previously imagined or commercially practiced. The products incorporating IntraMicron's patented technology are manufactured via high-speed, roll-to-roll papermaking and sintering processes. These "microfibrous media" products possess uniquely adaptable physical properties and performance characteristics that have broad applications across a wide range of markets including air security and biogrowth accelerators. More Information IntraMicron Website

Often referred to as the "gold standard" for measuring medication administration errors, the observation based AU MEDS™ system trains and certifies healthcare professionals to observe and examine each and every medication dose that is administered or omitted during observation periods. MedAccuracy™ provides proven process improvement tools, including proprietary software, that empower hospitals to reduce medication errors and operating costs. More Information MedAccuracy Website

Using a patented process utilizing supercritical carbon dioxide, MCR will provide turn-key plants for efficient recycling of nylon from used carpets on a local and regional level.  MCR Website

OcuMedic is a drug delivery and medical device company with proprietary technology that creates new architectures in polymeric films to enable enhanced loading and delayed release of therapeutics. Part of OcuMedic’s mission is to create a product line of therapeutic contact lenses to deliver medication for extended periods to address the considerable umet need for more efficacious ocular drug delivery. Ocumedic wins inaugural Alabama Launchpad contest